Canada’s life sciences sector is expanding quickly, but the pace of growth has exposed a gap between research and industry. Too many students and postdoctoral fellows finish their training without clear pathways into companies that need their expertise.
That disconnect is holding back commercialization, Dr. Tamana Yousof said at Edmonton’s kickoff of Life Sciences Week.
Yousof is a postdoctoral fellow at the University of Alberta, and she came to the province for the chance to build industry connections. Alongside her research with Nobel laureate Dr. Michael Houghton, she is developing entrepreneurial skills, learning the licensing process, and gaining access to networks of mentors and investors.
Her experience reflects a wider challenge. Across Canada, discoveries risk stalling before they reach patients and markets unless more talent moves from labs into companies that can scale innovations.
To help tackle that challenge, Applied Pharmaceutical Innovation (API), in partnership with Mitacs, today announced the Life Sciences Placement Program (LSPP). The initiative creates 1,000 paid internships nationwide, with Alberta expected to play a central role in building momentum for what API calls one of the largest applied training efforts of its kind.
It offers funding support and customized training to ensure participants gain practical, industry-ready skills. Placements cover the full spectrum of life sciences activity, from early-stage research and clinical validation to commercial manufacturing.
“The life sciences ecosystem here is evolving quickly for students, postdocs, and early career professionals,” said Yousof. “This presents a real opportunity to contribute, shape, and grow alongside a province that’s embracing change and driving innovation.”
Faster paths to industry
The placement program was designed to speed up how quickly talent moves into industry. API said it has cut approval timelines from four months to as little as three weeks. For companies, that means projects can bring in the right people when they need them, rather than waiting out a bureaucratic delay.
For Yousof, that change signals something larger.
Alberta isn’t just producing strong research, she said, but also building the conditions where scientists can gain entrepreneurial skills and industry connections earlier in their careers.
Andrew MacIsaac, CEO of API, describes the program as arriving at a pivotal time.
He says that Canada’s life sciences sector is pulling together in new ways, and that Alberta has the momentum to help push it forward.
“We’re thrilled to be able to announce this very impactful program at this key juncture,” MacIsaac said, pointing to the scale of activity taking place during Life Sciences Week as evidence that the province’s ecosystem has reached a turning point.
Mitacs leaders highlighted the program’s role in strengthening the talent pipeline across Alberta and Canada. In a media release, Mitacs CEO, Stephen Lucas, said the partnership connects “top-tier talent to industry, contributing to reduced costs to commercialization, accelerated growth, and a stronger workforce pipeline.”
Showcasing Alberta’s momentum
The launch of the LSPP set the tone for Life Sciences Week, which features 60 events and has attracted 5,000 registrations in Edmonton and Calgary. Programming includes facility tours, investment sessions, and discussions on everything from rural health delivery to commercialization pathways.
For Alberta, the initiative reflects a maturing ecosystem where industry and academia are increasingly aligned.
As Yousof told the audience at the event’s kick off in Edmonton, “this is a model designed not just to support individuals entering the workforce, but to strengthen competitive advantage, leveraging Canada’s world-class post-secondary institutions for economic growth.”
